UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Molecular oncology, 2019-12, Vol.13 (12), p.2515-2530

2019

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

BMC cancer, 2011-10, Vol.11 (1), p.422-422, Article 422

2011

Link zum Volltext

Verfügbarkeit prüfen

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2177-2184

2009

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer

PloS one, 2018-06, Vol.13 (6), p.e0197327-e0197327

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

PloS one, 2023-02, Vol.18 (2), p.e0277708-e0277708

2023

Link zum Volltext

Verfügbarkeit prüfen

Glycosylation Modulates Plasma Membrane Trafficking of CD24 in Breast Cancer Cells

International journal of molecular sciences, 2021-08, Vol.22 (15), p.8165

2021

Link zum Volltext

Verfügbarkeit prüfen

A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients

Journal of immunology research, 2014-01, Vol.2014, p.659294-12

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

Clinical cancer research, 2008-05, Vol.14 (9), p.2593-2600

2008

Link zum Volltext

Verfügbarkeit prüfen

Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5194-5202

2007

Link zum Volltext

Verfügbarkeit prüfen

KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer

PloS one, 2014-08, Vol.9 (8), p.e104902

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients

PloS one, 2011-01, Vol.6 (1), p.e15980

2011

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

Breast cancer research : BCR, 2008-01, Vol.10 (5), p.R80-R80, Article R80

2008

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting

Cancers, 2020-12, Vol.12 (12), p.3707

2020

Link zum Volltext

Verfügbarkeit prüfen

Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer

Modern pathology, 2013-02, Vol.26 (2), p.302-313

2013

Link zum Volltext

Verfügbarkeit prüfen

BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome

PloS one, 2013-12, Vol.8 (12), p.e84604-e84604

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients

Journal of clinical oncology, 2006-08, Vol.24 (23), p.3756-3762

2006

Link zum Volltext

Verfügbarkeit prüfen

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

PloS one, 2008-11, Vol.3 (11), p.e3695

2008

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide

PloS one, 2013-09, Vol.8 (9), p.e74611

2013

Link zum Volltext

Verfügbarkeit prüfen

Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome

Cancers, 2020-12, Vol.12 (12), p.3735

2020

Link zum Volltext

Verfügbarkeit prüfen

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

Life (Basel, Switzerland), 2022-06, Vol.12 (6), p.880

2022

Link zum Volltext

Verfügbarkeit prüfen

What's new on circulating tumor cells? A meeting report

Breast cancer research : BCR, 2010-07, Vol.12 (4), p.307-307, Article 307

2010

Link zum Volltext

Verfügbarkeit prüfen

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

Molecular oncology, 2018-01, Vol.12 (1), p.21-32

2018

Link zum Volltext

Verfügbarkeit prüfen

Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis

Supportive care in cancer, 2012-08, Vol.20 (8), p.1823-1829

2012

Link zum Volltext

Verfügbarkeit prüfen

Vaccination of Patients With Advanced Non–Small-Cell Lung Cancer With an Optimized Cryptic Human Telomerase Reverse Transcriptase Peptide

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2727-2734

2007

Link zum Volltext

Verfügbarkeit prüfen

Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer

Cancer Research and Treatment, 2019, 51(4), , pp.1518-1526

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Humans
(109)
Life Sciences & Biomedicine
(107)
Oncology
(99)
Female
(98)
Aged
(78)
Middle Aged
(77)
Adult
(67)
Tumors
(50)
Biological And Medical Sciences
(48)
Medical Sciences
(48)
Male
(47)
Breast Cancer
(41)
Prognosis
(36)
Breast Neoplasms - Pathology
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Chemotherapy
(25)
Aged, 80 And Over
(23)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(23)
Breast Neoplasms - Drug Therapy
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Chemotherapy And Pharmacology
(12)
Plos One
(12)
Breast Cancer Research : Bcr
(10)
Cancer Research
(10)
Lung Cancer
(9)
Journal Of Clinical Oncology
(6)
Anticancer Research
(5)
Clinical Cancer Research
(5)
International Journal Of Cancer
(5)
Bmc Cancer
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Glycosylation Modulates Plasma Membrane Trafficking of CD24 in Breast Cancer Cells

A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer

KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer

Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting

Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer

BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome

Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide

Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome

Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies

What's new on circulating tumor cells? A meeting report

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis

Vaccination of Patients With Advanced Non–Small-Cell Lung Cancer With an Optimized Cryptic Human Telomerase Reverse Transcriptase Peptide

Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer

Suchergebnisse filtern